340B’s Footprint in Medicare Part D Is Growing, Study Says

A JAMA Health Forum study co- authored by Sean Dickson found the 340B program's footprint in Medicare Part D is increasing.
340B covered entities captured nearly half (49.9%) of their 340B-eligible prescriptions billed to Medicare Part D in 2020, up from [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Improved Non-Profit Hospital Outlook Helped by 340B Payout: Moody’s

Matt Cahil
The 340B program could have a big impact on not-for-profit hospital finances, said Matt Cahill, assistant vice president for Moody’s.
The 2024 outlook for not-for-profit hospital and health systems improved from negative to stable, in part, due to the planned [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Hospitals Charge Higher Commercial Insurance Prices, Says PhRMA Funded Report

Neil Masia
Neil Masia, Ph.D., authored a Health Capital Group report that found 340B hospitals charge higher commercial insurance prices than non-340B hospitals.
The average hospital in the 340B program charges commercial insurers more than non-340B hospitals, according to a new report, which [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Program May Lead to Lower Charity Care, Says Drug Industry-Backed AIDS Group

Brandon Macsata
Brandon Macsata, CEO of ADAP Advocacy, said the group plans to publish data from its ongoing study on the 340B program later this year.
Enrollment in the 340B program was linked to diminished spending on charity care, according to preliminary findings from an ongoing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Hospitals’ Community Benefit Surges in 2020, Says Hospital-Backed Report

AHA
The American Hospital Association published a study that found 340B hospitals' community benefit increased significantly in 2020.
The community benefits provided by 340B hospitals surged by $16.5 billion, or 24%, in the latest year analyzed by a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Most 340B DSH Hospitals Provide Below-Average Charity Care, Says Analysis Backed by Critics

Bob Dold, a spokesperson for AIR340B, said the 340B program "has not translated into a stronger safety-net” after a drug industry backed analysis found 340B DSH hospitals provide below-average charity care.
The majority of 340B disproportionate share hospitals (DSH) provide charity care at lower rates than the national hospital average, found [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Paper Warns on Duplicate Discounts from 340B Ceiling Price, Medicare Maximum Price

An Avalere study suggested 340B duplicate discounts could increase as a result of Medicare drug price negotiations.
Timelines for manufacturers to provide new Medicare “maximum fair prices” (MFPs) and 340B ceiling prices on drugs are misaligned, risking [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

In Study, Health Center’s Patients Laud its 340B Drug Assistance Program

A recent study suggested a 340B cash discount program was associated with better outcomes for patients with diabetes.
A recent study found positive patient benefits from a 340B cash discount program. Low-income patients said saving money on injectable [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Leading Senator, Provider Groups Publish Dueling Reports on Nonprofit Hospitals

Sen. Bernie Sanders (I-Vt.) and two hospital groups were at odds over whether nonprofit hospitals provide sufficient levels of community benefit.
A leading senator and two major hospital trade groups recently published conflicting reports on the level of community benefit that [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Health, Researchers Spar over Biosimilar Study

Maureen Testoni headshot
Maureen Testoni, president and CEO of 340B Health, said she anticipates bipartisan legislation on drugmaker 340B contract pharmacy restrictions.
Researchers rejected criticism of a recent study in an academic journal they co-authored from the leader of a 340B hospital [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live